Cellivery Therapeutics, Inc.
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Public
- Established
- 2014-03-06
- Employees
- 101
- Market Cap
- -
- Website
- http://www.cellivery.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)β’ Click on a phase to view related trials
Phase 1
1 (100.0%)iCP-NI - Safety, Tolerability, Pharmacokinetic, and Immunogenicity Study in Healthy Male and Female Subjects
- First Posted Date
- 2023-02-23
- Last Posted Date
- 2025-09-19
- Lead Sponsor
- Cellivery Therapeutics, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT05740280
- Locations
- πΊπΈ
Labcorp Clinical Research Unit Inc., Daytona Beach, Florida, United States
News
No news found